About Us

Welcome to our site. The discovery of an effective treatment for glaucoma requires a collective effort from patients, clinical trial participants, support staff, healthcare professionals, and researchers, among others. We want to hear from you, please email us at team@eliosvision.com.

Our Medical Advisory Board


Ike K. Ahmed, MD, FRCSC

Assistant Professor, University of Toronto


Keith Barton, MD, FRCP, FRCS

Ophthalmic Surgeon, Moorfields Eye Hospital, London


Rosa Braga-Mele MD, MEd, FRCSC

Professor of Ophthalmology, University of Toronto


Louis B. Cantor, MD

Professor of Ophthalmology, Indiana University


Maria Isabel Canut, MD

Professor, Barraquer Ophthalmology Center, Barcelona


Eric Donnenfeld, MD

Co-founder, Ophthalmic Consultants of Long Island & Connecticut


Murray Johnstone, MD

Professor, University of Washington


Richard A. Lewis, MD

Co-founder, Sacramento Eye Consultants


Antonio Moreno Valladares, MD, PhD

Surgeon, University Hospital of Albacete


Thomas F. Neuhann, MD

Medical Director & Founder, Laser Eye Center, Munich


Nathan Radcliffe, MD

Surgeon, New York Eye & Ear Infirmary


Thomas W. Samuelson, MD

Partner & Attending Surgeon, Minnesota Eye Consultants


Marc Töteberg-Harms, MD, FEBO

Assistant Professor, University of Munich


ELIOS combined with cataract surgery delivers significant IOP reduction out to 8 years

Today, ELIOS Vision, Inc. announced the eight-year follow up results of its novel ELIOS® Excimer Laser Trabeculostomy procedure combined with cataract surgery.
Read More >

ELIOS Vision’s Excimer Laser Trabeculostomy Procedure Receives New CPT Codes from American Medical Association

Two Category III CPT codes are approved to report trabeculostomy ab interno by laser with or without the use of an ophthalmic endoscope. The trabeculostomy procedure restores the “natural flow” of aqueous fluid using the company’s non-thermal, precise excimer laser system, ELIOS ELT.
Read More >

Leading North American and European Glaucoma Leaders Highlight Significant Effectiveness and Favorable Safety Profile of ELIOS in Review Article

Ten independent clinical studies demonstrate significant intraocular pressure (IOP) lowering effect of ELIOS with few complications and no residual device remaining in the angle.
Read More >

ELIOS Vision, Inc. Announces Medical Advisory Board

Glaucoma key opinion leaders join the ELIOS Vision Medical Advisory Board.
Read More >